Scientific Reports · 2017 · 19 citations · 31 references
PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryTargeted Drug DeliveryDrug Delivery EngineeringLigand BindingNanocarriers For TherapeuticsNanomedicineNucleic Acid DeliveryTargeting LigandsAptamer RecognitionAptamer Targeting LigandsAptamer-based ProbesAptamer-based TargetingAptamersClinical RemissionStimuli-responsive Active TargetingTarget-ligand Interactions
A polyrotaxane-based nanoconstruct with pliable structure carrying a chemotherapeutic drug was developed for targeting circulating lymphoblastic leukaemia cells in a fluidic environment of blood vessels in vivo. By introducing lymphoblast targeting aptamer DNA through cyclodextrin, threaded in poly(ethylene glycol) as polyrotaxane, target aptamer slides along the long polymeric chain and actively search for target ligand, leading to active targeting in dynamic fluidic system which is enhanced by up to 6-fold compared with that of control carriers with non-sliding targeting ligands. Moreover, the drug carrier was made stimuli-responsive by employing i-motif DNA to selective releases of its payload at intracellular acidic condition. These combined features resulted in the effective remission of lymphoblastic leukaemia both in vitro and in dynamic blood vessels in vivo.
31
George W. Sledge, Donna Neuberg, Patricia Bernardo et al. · Journal of Clinical Oncology · 2003 · 707 citations
Medicine, Oncology, Pharmacology +15
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
D. Hoelzer, E. Thiel, H. Löffler et al. · Blood · 1988 · 590 citations · Full text
Medicine, Hematology, Oncology +12